Excellent Early Outcomes of Combined Chemotherapy With Arsenic Trioxide for Stage 4/M Neuroblastoma in Children: A Multicenter Nonrandomized Controlled Trial

This nonrandomized, multicenter cohort, open-label clinical trial evaluated the efficacy and safety of combined chemotherapy with arsenic trioxide (ATO) in children with stage 4/M neuroblastoma (NB). We enrolled patients who were newly diagnosed with NB and assessed as stage 4/M and received either...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chunmou, Peng, Xiaomin, Feng, Chuchu, Xiong, Xilin, Li, Jianxin, Liao, Ning, Yang, Zhen, Liu, Aiguo, Wu, Pingping, Liang, Xuehong, He, Yunyan, Tian, Xin, Lin, Yunbi, Wang, Songmi, Li, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420893/
https://www.ncbi.nlm.nih.gov/pubmed/33858561
http://dx.doi.org/10.3727/096504021X16184815905096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420893/
https://www.ncbi.nlm.nih.gov/pubmed/33858561
http://dx.doi.org/10.3727/096504021X16184815905096

Ejemplares similares